Amanda Mullen

Chief Operating Officer

Ms. Mullen received her Bachelor of Science degree in biology with a minor in business from Dalhousie University. During her studies she worked as a Research Assistant at ReveraGen BioPharma Inc. in the Children’s National Medical Center (CNMC). During her time there, she studied the effects of corticosteroids on skeletal muscle cells and the resorption rate of human osteoblasts. While working with ReveraGen, she also participated in preclinical studies in muscular dystrophy and sickle cell mouse models. Ms. Mullen received training in Good Laboratory Practice (GLP) for Pre-Clinical Testing and in Pharmaceutical and BioPharmaceutical Quality Control Laboratories  through CfPIE. She uses her science and business background to help lead AGADA’s organizational development, oversee business operations and day-to-day management of preclinical studies and clinical testing programs.

Related Links